Aziz N, Buchan I, Taylor C, Kingsland C R, Lewis-Jones I
University of Liverpool, United Kingdom.
Fertil Steril. 1996 Dec;66(6):1000-8. doi: 10.1016/s0015-0282(16)58697-x.
To evaluate a novel expression of sperm morphological parameters, the sperm deformity index, as a predictor of fertilization in vitro.
Prospective blind clinical trial.
Academic tertiary referral center.
INTERVENTION(S): Detailed sperm morphological assessment applying strict morphological criteria and a multiple entry technique for an unselected male population undergoing IVF. The sperm deformity index, defined as the average number of deformities per sperm assessed, was calculated.
PATIENT(S): One hundred fifty-eight patients undergoing IVF treatment. Females with conditions negatively influencing fertilization were excluded.
MAIN OUTCOME MEASURE(S): Fertilization rates and pregnancy.
RESULT(S): Seventy-three percent of patients achieved fertilization. Patients achieving fertilization had a significantly higher median proportion of normal forms and a significantly lower median sperm deformity index than the nonfertilizers. The receiver operator characteristic (ROC) curves identified cutoff points that maximized the sum of sensitivity and specificity at sperm deformity index 1.6 and normal forms 4%. The sperm deformity index had a greater sensitivity (96%), specificity (72%), positive predictive value (90%), and negative predictive value (86%) than the proportion of normal sperm morphology (87%, 69%, 89%, 66%, respectively) at the optimal cutoff points. The area under the ROC curve was greater for the sperm deformity index (0.875) than for the proportion of normal sperm morphology (0.622). Achieving pregnancy did not correlated with sperm morphology.
CONCLUSION(S): The sperm deformity index is a more reliable predictor of the outcome of fertilization in vitro than the proportion of normal sperm morphology and can assist to identify patients who require techniques such as intracytoplasmic sperm injection.
评估精子形态参数的一种新表达形式——精子畸形指数,作为体外受精受精率的预测指标。
前瞻性盲法临床试验。
学术性三级转诊中心。
对接受体外受精的未选择男性群体应用严格形态学标准和多次进入技术进行详细的精子形态评估。计算精子畸形指数,其定义为每个评估精子的平均畸形数。
158例接受体外受精治疗的患者。排除有对受精产生负面影响情况的女性。
受精率和妊娠情况。
73%的患者实现受精。实现受精的患者正常形态的中位数比例显著更高,精子畸形指数的中位数显著更低。受试者工作特征(ROC)曲线确定了在精子畸形指数为1.6和正常形态为4%时使敏感性和特异性之和最大化的截断点。在最佳截断点,精子畸形指数的敏感性(96%)、特异性(72%)、阳性预测值(90%)和阴性预测值(86%)均高于正常精子形态比例(分别为87%、69%、89%、66%)。精子畸形指数的ROC曲线下面积(0.875)大于正常精子形态比例的ROC曲线下面积(0.622)。实现妊娠与精子形态无关。
精子畸形指数比正常精子形态比例更可靠地预测体外受精结局,可有助于识别需要胞浆内单精子注射等技术的患者。